Comparison of the antituberculous activity of morphazinamide and pyrazinamide on chronic experimental tuberculosis. I. The antimycobacterial efficacy made in vitro and in vivo.
D000636:Aminosalicylic Acids / Q000494:pharmacology; D000818:Animals; D000995:Antitubercular Agents / Q000494:pharmacology*; D001391:Azo Compounds / Q000494:pharmacology; D003470:Culture Media; D066298:In Vitro Techniques; D007538:Isoniazid / Q000494:pharmacology; D051379:Mice; D009169:Mycobacterium tuberculosis / Q000187:drug effects*; D011719:Pyrazines / Q000494:pharmacology; D013307:Streptomycin / Q000494:pharmacology; D014397:Tuberculosis, Pulmonary / Q000188:drug therapy*; D014400:Tuberculosis, Splenic / Q000188:drug therapy*
D000636:Aminosalicylic Acids; D000995:Antitubercular Agents; D001391:Azo Compounds; D003470:Culture Media; D011719:Pyrazines; D007538:Isoniazid; D013307:Streptomycin